MONROVIA, Calif., Feb. 27, 2013 -- /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported revenue for the fourth quarter ended December 28, 2012 of $16.5 million compared to $16.4 million reported for the fourth quarter of 2011. The effect of foreign currency exchange reduced sales by $275,000 during the quarter. The results included sales of $8.8 million of the Company’s Visian® ICL product portfolio and $6.8 million of its IOL products.
